Home Other Building Blocks 2-Butyn-1-ol

2-Butyn-1-ol

CAS No.:
764-01-2
Catalog Number:
AG003GTW
Molecular Formula:
C4H6O
Molecular Weight:
70.0898
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$13
- +
5g
98%
In Stock USA
United States
$19
- +
25g
98%
In Stock USA
United States
$82
- +
100g
98%
In Stock USA
United States
$250
- +
Product Description
Catalog Number:
AG003GTW
Chemical Name:
2-Butyn-1-ol
CAS Number:
764-01-2
Molecular Formula:
C4H6O
Molecular Weight:
70.0898
MDL Number:
MFCD00002914
IUPAC Name:
but-2-yn-1-ol
InChI:
InChI=1S/C4H6O/c1-2-3-4-5/h5H,4H2,1H3
InChI Key:
NEEDEQSZOUAJMU-UHFFFAOYSA-N
SMILES:
CC#CCO
EC Number:
212-113-4
UNII:
US5293942K
NSC Number:
222371
Properties
Complexity:
62.2  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
70.042g/mol
Formal Charge:
0
Heavy Atom Count:
5  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
70.091g/mol
Monoisotopic Mass:
70.042g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
20.2A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.2  
Literature
Title Journal
Platinum-catalyzed multi-step reaction of propargyl alcohols with N-heteroaromatics. Chemistry, an Asian journal 20100104
Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE. Bioorganic & medicinal chemistry letters 20090701
Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors. Bioorganic & medicinal chemistry 20090601
Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket. Bioorganic & medicinal chemistry 20070915
(eta(5)-Cyclopentadienyl)(3-hydroxy-3-methylbut-1-ynyl-kappaC(1))(triphenylphosphine-kappaP)nickel(II): novel O-H...pi bonding in an organometallic molecule. Acta crystallographica. Section C, Crystal structure communications 20070701
Synthesis of the 5-phosphono-pent-2-en-1-yl nucleosides: a new class of antiviral acyclic nucleoside phosphonates. Bioorganic & medicinal chemistry 20070215
The use of silicon-based tethers for the Pauson-Khand reaction. Beilstein journal of organic chemistry 20070101
Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates. Bioorganic & medicinal chemistry letters 20051001
Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors. Journal of medicinal chemistry 20041202
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates. Bioorganic & medicinal chemistry letters 20030818
Dehydration reaction of hydroxyl substituted alkenes and alkynes on the Ru(2)S(2) complex. Journal of the American Chemical Society 20021106
Acyclic nucleoside analogues as novel inhibitors of human mitochondrial thymidine kinase. Journal of medicinal chemistry 20020912
Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group. Bioorganic & medicinal chemistry letters 20020422
Properties